Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.

BMC pulmonary medicine - 2 Nov 2017

Tai Anna S, Sherrard Laura J, Kidd Timothy J, Ramsay Kay A, Buckley Cameron, Syrmis Melanie, Grimwood Keith, Bell Scott C, Whiley David M

Abstract excerpt

BACKGROUND: Pulmonary exacerbations in cystic fibrosis (CF) remain poorly understood and treatment is usually targeted at Pseudomonas aeruginosa. Within Australia a predominant shared P. aeruginosa strain (AUST-02) is associated with greater treatment needs. This single centre study assessed temporal shared strain population dynamics during and after antibiotic treatment of exacerbations. METHODS: Sputum was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Cystic Fibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forced Expiratory Volume

Share to Population Dynamics

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Share to Respiratory Tract Infections

Share to Sputum

Source

Open in PubMed Open full text

Identifiers

PMID: 29096618
DOI: 10.1186/s12890-017-0482-7
PMCID: PMC5667482

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.PMID 29096618Read ↗

Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.Semantic proximity Read ↗

Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis.Semantic proximity Read ↗

Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary diseaseSemantic proximity Read ↗

Pseudomonas aeruginosa infection and persistence mechanisms in cystic fibrosis patientsSemantic proximity Read ↗

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.Semantic proximity Read ↗

Pseudomonas aeruginosa genetics and virulence in cystic fibrosis and bacteraemiaSemantic proximity Read ↗

Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre.Semantic proximity Read ↗

Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient.Semantic proximity Read ↗

Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 daysSemantic proximity Read ↗

Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.Semantic proximity Read ↗

Within-patient evolution of Pseudomonas aeruginosa populations during antimicrobial treatment.Semantic proximity Read ↗

Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic FibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.